Deep tech and science early stage VC
2050 Capital is an early stage deep technology and science VC organisation. We invest in transformative and defensible innovation that impacts large fundamental sectors.
We focus on enterprise software (with a deep science component), computational biotech, and engineering and science ventures. Our investment approach is disciplined and surgical, backed by deep due diligence. We surround ourselves with experts in every deal, invest with conviction, and close 2-6 deals per year. We write $200-500k seed checks and up to $3m in subsequent rounds. Over 50% of our investments have been in follow-ons.
We believe that to exercise significant positive change one must invest significant time and effort. No shortcuts. This goes for founders and for investors. From the first check onward we assist our portfolio companies with business development, strategy, and next stage fundraising. Once we become your investors, we become your partners.
If you have audacious, nearly impossible goals, and are on the way towads them, we'd love to get to know you. Please get in touch.
2050 Capital in Figures
- $200-500k seed checks
- up to $3m follow-on checks
- 12 portfolio companies (21 transactions)
- 70% of portfolio appreciated
Additive MES & workflow automation software
The leader in Brain-Computer Interface technology
Distributed, spatial and scalable computing for web 3.0
Quantum security technologies for critical sectors
Diagnostics of gastro-intestinal conditions using genomic sequencing
Open source security for developers
Strongly-typed database and query language
Fund formation and governance platform
Prescriptive analytics & intelligent triage for service operations
AMFG, Apr 2023
The Telegraph, Mar 2023
Imperial College London, Feb 2023
TechCrunch, Dec 2022